Objectives: Pancreatic fibrosis is a characteristic feature of chronic pancreatic injury, which is a result of the imbalance between synthesis and degradation of extracellular matrix (ECM) proteins. Transforming growth factor-b (TGF-b) plays a central role in biosynthesis and turnover of the ECM. In this study, we evaluated the role of TGF-b signaling in pancreatic fibrosis induced by repetitive acute pancreatic injuries with mice of dominant-negative mutant of TGF-b receptor II selectively in pancreas.
C
hronic pancreatitis is characterized histologically by an irreversible and irregular scarring of exocrine parenchyma with the precedent ductal changes by inflammatory processes 1 and is also defined morphologically as progressive pancreatic fibrosis and atrophy of the pancreatic exocrine cell mass. 2 Long-term follow-up of patients with alcoholic pancreatitis revealed that the progression from acute to chronic pancreatitis might be closely related to the incidence of an acute attack. 3, 4 Previously, our experiments and those of others supported that repeat injections of the pancreatic secretagogue cerulein induced significant fibrosis of the pancreas in a mouse model. [5] [6] [7] Therefore, long-standing pancreatic inflammation might be the basis for pancreatic fibrosis and chronic pancreatitis. The difficulties in proving this in humans necessitated the adoption of animal model and the animal approaches provided understanding of the mechanism of the fibrogenesis in developing chronic pancreatitis and served as a more accelerated in vivo model for chronic fibrosing pancreatitis.
Extracellular matrix (ECM) plays a central role in the maintenance of normal tissue architecture. It is now evident that ECM turnover including synthesis, secretion, and degradation is an essential feature of the tissue remodeling that accompanies physiologic as well as pathologic processes. 8 The alteration in the balance between synthesis and degradation of ECM proteins has been often detected in pathologic processes leading to the development of pancreatic fibrosis. Various peptide growth factors are involved in the regulation of ECM turnover under normal conditions as well as pathologic fibrotic reactions. 9, 10 Among the factors involved in the regulation of ECM turnover, the members of the transforming growth factor-b (TGF-b) family play multiple roles in controlling these processes, not only in the pancreas, but also in the kidney, liver, breast, and other tissue. [11] [12] [13] [14] [15] TGF-b is a family of cytokines involved in various pathophysiologic processes, including cell proliferation, differentiation, development, angiogenesis, wound healing, and fibrosis. 16 Excessive TGF-b activity is the cause of increased scarring and fibrosis in disease including glomerulonephritis, lung fibrosis, liver cirrhosis, and cardiac fibrosis after infarction. [17] [18] [19] While TGF-b1 activity was higher than TGFb2 or TGF-b3 in human acinar cells, the activities of three subtypes of TGF-b in ductal cells were similar. The elevation of TGF-b accompanied by the expression of collagen and fibronectin has been shown during tissue regeneration after acute pancreatitis. 13, 20 This TGF-b-induced collagen expression is directed by smad proteins binding to the collagen I a2 promoter. 21 TGF-b could be a potential mediator providing the pathogenic link between acute and chronic pancreatitis. 22 TGF-b1 null mice showed multifocal inflammatory infiltrations in multiple organs, including the pancreas. 23 However, because of the short life span and severe inflammatory infiltrations in most organs, it is impossible to study the effect on individual organs for susceptibility to disease. Therefore, we have used transgenic overexpression of a dominant negative mutant form of the TGF-b receptor II (TGF-b dnRII) driven by tissue-specific promoters to study the tissue-restricted functional inactivation of TGF-b RII. The aim of this study was to evaluate the significance of TGF-b1 signaling in fibrogenesis of chronic pancreatitis using dominant-negative mutant TGF-b RII mice.
METHODS

Animals
To determine the effect of TGF-b signaling in developing pancreatic fibrosis, TGF-b signaling was conditionally inactivated by overexpressing a dominant-negative mutant form of TGF-b type II receptor in the pancreas under the control of pS2/TFF1 mouse trefoil peptide promoter as previously described. 24 Briefly, since pS2/TFF1 was proven to be highly expressed in the stomach and pancreas, we made the transgene construct containing the pS2 promoter sequence followed by the TGF-b type II fragment spanning +1 to +911, into which transgene we inserted 2 more following the gene sequence including the hemagglutinin (HA) tag sequence (TATGATGTTCCTGATTATGCTAGCCTC) and a segment of the mouse protamine 1 gene (mP) tract that provides an intron and a polyadenylation site. The 3.8-kb fragment, transgene, was microinjected into fertilized eggs (FVB/N strain background). We obtained 4 lines of transgenic mice, called pS2-dnRII-1 to pS2-dnRII-4. After evaluating genotyping and phenotyping, pS2-dnRII-3, which shows the highest expression of transgene in the pancreas, was used for the current experiment. On gross and pathologic evaluation, the pancreas did not differed at all compared with that of wild-type littermates, but the expression of MHC class II antigens was significantly increased in pS2-dnRII mice. 24 HA antibody (LCRC, NCI) could detect the presence of dnRI, and we found that there was no difference in the expression of signaling molecules of TGF-b, smad-3, or -4 between pS2-dnRII and wild-type littermates.
Experimental Procedures
A total of 60 FVB/N mice were divided into 3 groups: sham-injected controls (n = 20), the wild-type littermates receiving repeated injections of cerulein (n = 20), and the pS2-dnRII transgenic mice receiving repeated injections of cerulein (n = 20) as described below. Also, the age-matched, shamtreated normal control group of 8-week-old male FVB/N mice (Charles River Japan) weighing 20-22 g were housed in isolated cages (4 mice/cage) and fed rodent chow pellets (Purina Korea, Seoul, Korea) ad libitum. In the wild-type littermates and the pS2-dnRII transgenic mice groups, following a 5-day equilibration period, the mice were treated with cerulein (Sigma, St. Louis, MO), 40 mg/kg intraperitoneally every hour for 6 hours to induce acute pancreatitis. The abdominal fur was swabbed with an antiseptic before injections. Induction of acute pancreatitis was repeated every Monday and Thursday for a period of 5 or 10 weeks (Fig. 1) . At predetermined time points after the first treatment, animals were killed at 4 days following the final cerulein treatment by cervical dislocation.
Histologic Evaluation for Pancreatic Fibrosis
For light microscopic examination, pancreatic specimens were fixed overnight in 10% buffered formaldehyde solutions, embedded in paraffin, and stained with hematoxylin-eosin and Masson's trichrome. Representational pathologies according to severities of pancreatic fibrosis are shown in Figure 2A . For that, we used the following criteria of histologic scoring: 0, none; 1, focal periductal fibrosis; 2, diffuse periductal fibrosis; 3, focal acinar atrophy; 4, diffuse acinar atrophy. Two independent pathologists unaware of each group scored the degree of pancreatic fibrosis based on the above criteria. Hence, the pancreatic fibrosis was not FIGURE 1. Schematic presentation of experimental protocol. The experimental animals (n = 60) were divided into 3 groups: normal FVB/N mice, the wild-type littermates, and pS2-dnRII transgenic mice. To induce acute pancreatitis, the pancreatic secretagogue cerulein was repeatedly injected, 40 mg/kg intraperitoneally 6 times every hour per day. The injection was repeated twice a week and the mice were sacrificed after 5 or 10 weeks. Sham treatment with normal saline was given to normal control mice. Half of the mice were killed at 5 weeks of treatment and the remaining was killed at 10 weeks after the trial. Sham treatment consisted of injecting normal saline intraperitoneally. in a whole pancreas to the same degree; arbitrarily, whole pancreatic sections were divided into 5 regions and the pancreatic scoring for fibrosis was performed and the degree of fibrosis was presented as a mean.
Biochemical Assays for Pancreatic Inflammation and Fibrosis Serum Amylase
Serum levels of amylase were measured with Infinity kit from Sigma in colorimetric method using 5E-pNF-G7 as a substrate according to the manufacturer's directions.
Pancreatic Collagen Amount
Pancreatic tissue was homogenized in 33 volumes (mol/g) of 0.5 mol/L acetic acid using a Poltroon PCU-2 homogenizer (Kinematical, Lausanne, Switzerland), and the homogenate was disrupted by repetitive freezing-thawing and sonication for 2 minutes. Total pancreatic proteins were measured by the Bradford protein assay method and a total of 10 mg of proteins was subjected to collagen extraction. The fraction of collagen after the acetic acid extraction, which was composed of cross-linked collagen, was then mixed with 1 mL of Sircol dye at 37°C for 60 minutes and the collagen dye complex was precipitated. The collagen contents of the acid FIGURE 2. Attenuated pancreatic fibrosis in the pS2-dnRII transgenic mice. Since the whole pancreas showed heterogenous pancreatic pathology, we arbitrarily divided the whole pancreas into 5 segments and the degree of pancreatic fibrosis was evaluated with the following criteria: scoring guidelines for assessing the degree of pancreatic fibrosis were 0 (none), 1 (focal periductal fibrosis), 2 (diffuse periductal fibrosis), 3 
Western Blot Analysis of ECM Proteins and Inflammatory Mediators
Total proteins were extracted from the pancreas, electrophoresed on a 12% SDS-PAGE gel, and transferred to PVDF membrane using a semidry transfer system (Hoeffer Phamacia Biotech, San Francisco, CA). Membranes were blocked in 5% nonfat dry milk and probed with specific antibodies corresponding to collagen a1 (C-18), ICAM-1 (M-19), fibronectin (H-300), COX-2 (C-20), IkBa (C-21), metallothionein (FL-61), a-tubulin (all purchased from Santa Cruz Biotechnology, Santa Cruz, CA), and nitrotyrosine (Zymed Laboratories, San Francisco, CA). The blots were incubated with 1:2000 diluted HRP-conjugated secondary antibodies. Immunocomplex ws detected using ECL detection kit (Amersham Pharmacia Biotec, Piscataway, NJ).
Measurement of Transcriptional Activity With Electrophoretic Mobility Shift Assay (EMSA)
The nuclear fractions for EMSA were prepared using NE-PER Nuclear and Cytoplasmic Extraction Kit (Pierce, Rockford, IL) following the manufacturer's protocol. Sequences of double-stranded oligonucleotides used for EMSA were as follows: 5#-AGT TGA GGG GAC TTT CCC AGG C-3# for NF-kB, 5#-ATT CGA TCG GGG CGG GGC GAG C-3# for SP-1, and 5#-CGC TTG ATG AGT CAG CCG GAA-3# for AP-1, and the oligonucleotides were labeled with biotin 3# End DNA Labeling Kit (Pierce). EMSA reaction was performed with LightShift Chemiluminescent EMSA Kit (Pierce) according to the manufacturer's instructions.
Isolation and Culture of Pancreatic Stellate Cells (PSCs)
PSCs were isolated by a modification of the method described by Apte et al. 25 Briefly, pancreatic tissue from 6 mice weighing approximately 25 g each after the administration of vitamin A (30,000 IU/100g body weight) was pooled, minced with scissors, and digested with 0.02% proteinase, 0.05% collagenase P, and 0.1% DNAse in Gey's balanced salt solution (GBSS). The vitamin A treatment (30,000 IU/100 g body weight) was continued for 5 days intraperitoneally; the rationale for this was based on vitamin A treatment increasing the yield of PSC isolations. Digested tissue was pipetted through narrow orifices successfully and then filtered through a 150-mm nylon mesh. Cells were washed and resuspended in 9.5 mL GBSS containing 0.3% BSA. The cell suspension was mixed with 10 mL of 28.7% (wt/vol) of Nycodenz in Gey's solution without salt. The Nycodenz gradient was prepared by layering the cell suspension in Nycodenz underneath 6 mL Gey's solution with BSA in a 50-mL centrifuge tube. The gradient was centrifuged for 20 minutes at 1400g. The cells of interest separated into a fuzzy band just above the interface of the Nycodenz cushion and the GBSS with BSA. This band was harvested, and the cells were washed and resuspended in Dulbecco medium containing 10% fetal calf serum, 4 mmol/L glutamine, and antibiotics. The yield of PSC isolations was 2 3 10 4 cells per each centrifugation, and we could observe the typical morphology of stellate cells, whose purity was about 80% after isolation, but it increased to 98% after 2-3 passages. Cells were maintained at 37°C in a humidified atmosphere of 5% CO 2 /95% air.
Transient Transfection of TGF-b1 dnRII Into Isolated PSCs and Immunofluorescence Staining
The dominant-negative form of human TGF-b RII spans +1 to +911, featuring the lack of an active phosphorylation domain of serine threonine kinase of TGFb type II receptor, of which segment of cloned gene was inserted into mammalian expression vector, pCB7. Plasmid DNA was transfected with DOTAP liposomes according to the manufacturer's instructions (Roche, Mannheim, Germany). Briefly, after PSC cells, which were established from wildtype littermates, were seeded at a 50% confluency, 5mg of TGF-b, plasmid DNA or pS 2 -dnRII plasmid DNA was transfected into the cells with 30 mg of DOTAP. Six hours after transfection, the culture medium was replaced by selection medium containing hygromycin B since the vector used contains a bacterial hygromycin promoter controlling the transcription of the cDNA. To activate PSCs, 5 ng recombinant TGF-b1 (a kind gift of Dr. S. J. Kim, NCI, NIH, Rockville, MD) was treated in each cultured cell. Dispersed single cells (2 3 10 5 cells per well) were grown on 22 3 22 3 1-mm 3 glass coverslips in 6-well culture plates. After 24 hours of culture, cells were fixed in ice-cold methanol for 5 minutes in a 220°C freezer and permeabilized with 1% Triton X-100/ PBS for 10 minutes at room temperature. The cells were blocked with 5% BSA for 30 minutes and probed with antibodies corresponding to asmooth muscle actin (a-SMA) and type I collagen (1:100 diluted in 5% BSA) (Santa Cruz Biotechnology) for 2 hours. Immunoreactive proteins were visualized with a Cy3 or Cy5 fluorescence-conjugated secondary antibody under a confocal microscope (Olympus, BX50F, Japan).
RESULTS
Pancreatic Fibrosis Was Remarkably Attenuated in Transgenic Mice With Disrupted TGF-b Signaling
Repeated injections of cerulein for 5 weeks provoked a significant fibrosis in pancreatic tissues, presenting with severe atrophy, pancreatic fibrosis, and discolored pancreatic acinar. The changes of fibrotic pancreatitis were more aggravated after 10 weeks of repeated injections of cerulein (Fig.  2B,C) . Since these pancreatic changes were not seen entirely in whole pancreatic tissues in evenly, we divided the whole sections of pancreatic tissue into 5 sections and determined the fibrotic score for each section separately for each mouse and added the total for each mouse. The mean changes of fibrosis score were shown in Figure 2C . Remarkable fibrosis were found in wild-type littermates after repeated cerulein injections, but the fibrotic scores were significantly decreased in pS2-dnRII mice, and these differences were observed at e74 q 2005 Lippincott Williams & Wilkins both 5 and 10 weeks after repeated injections of cerulein (P , 0.001), signifying that the transgenic mice showing the loss of TGF-b signaling in pancreata were resistant to fibrogenic stimuli provoked by repeated injections of cerulein for 5 or 10 weeks. However, the serum amylase levels were more elevated than before administration of cerulein and were similar between wild-type littermates and pS2-dnRII transgenic mice, signifying the development of edematous pancreatitis after cerulein administration (data not shown).
Changes of Several ECM Proteins in pS2-dnRII Transgenic Mice
Using the pancreatic tissue homogenates, the collagen amounts in the tissue were measured with a biochemical method using the Sircol collagen assay kit, and there were significantly decreased amounts of collagen formed in pS2-dnRII transgenic mice compared with wild-type littermates of 5 and 10 weeks (P , 0.001), respectively (Fig. 3A) . These experimental results supported the previous histologic findings (Fig. 2B,C ) that conditional loss of TGF-b signaling in the pancreas led to significant attenuation of fibrogenic activity driven by repeated pancreatic inflammation.
We further measured the respective changes of pancreatic ECM proteins by Western blot analysis; the results are shown in Figure 3B ,C. Similar to the biochemical changes seen in Figure 3A , the levels of pancreatic collagen I were significantly increased after either 5 or 10 weeks of cerulein injections. The expression of ICAM-1 and fibronectin was strongly induced after 5 weeks' administration of cerulein in spite of no change in a-tubulin served as house keeping protein. The increased ECM proteins by cerulean injection significantly were decreased in pS2-dnRII transgenic mice (Fig. 3B) . Even though the duration of the cerulein-induced pancreatic injury was well correlated with an increased amount of the ECM proteins in wild-type littermates, pS2-dnRII transgenic mice failed to induction of the ECM proteins. All of these results supported that chronic pancreatic injury provoked by the repeated injections of cerulein induced the apparent pancreatic fibrogensis via excessive accumulation of ECM proteins and controlling of TGF-b signaling could attenuate the synthesis of ECM proteins, resulting in prevention of the pancreatic fibrosis.
DNA Binding Activities of NF-kB and AP-1 Are Responsible for Transcription of Fibrogenic Response Genes by Repeated Injections of Cerulein
To evaluate whether several proinflammatory and fibrogenic proteins critical for the development of pancreatitis were influenced by transcriptional factors such as NF-kB, AP-1, and SP-1, EMSA was performed (Fig. 4) . As shown in Figure   FIGURE 3 . Low expression of ECM proteins in pS2-dnRII transgenic mice. Collagen amounts (mg/mg pancreatic protein) were measured in pancreatic tissue homogenates and presented using a bar graph (A). To detect the expression of major ECM proteins (collagen I, ICAM-1, and fibronectin) in pancreatic tissue, Western blotting was performed with total pancreatic proteins extracted from cerulein-administered mice for 5 weeks (B) and 10 weeks (C). Top, The results of Western blot; bottom, the measurements of densitometer of Western blot. *Statistical significance (P , 0.01).
4A, NF-kB, one of the principal redox signaling-associated transcription factors, was activated by the repeated injections of cerulein. Similar to NF-kB, AP-1 DNA binding activities were increased in wild-type littermates after repeated injections of cerulein. However, the DNA binding activities of transcriptional factors were reduced in pS2-dnRII transgenic mice compared with wild-type littermates. SP-1 did not showed notable changes with the loss of TGF-b signaling. Next, we performed Western blotting analysis of several proinflammatory mediators, all of which are known to be transcriptionally regulated by NF-kB or AP-1 (Fig. 4B) . These changes in NF-kB were further proved by the changes of IkBa, which showed significant expression of IkBa in pS2-dnRII mice compared with wild-type littermates, supporting the active involvement of redox signal-associated inflammatory activities after repeated injections of cerulein in wild-type mice but less activated in mice with defective TGF-b signaling. COX-2, nitrotyrosine, and metallothionein-1 were remarkably or slightly increased after induction of acute pancreatitis with cerulein, but the levels of all these mediators were apparently decreased in pS2-dnRII transgenic mice. These results indicated that the induction of pancreatic fibrosis with repeated injections of cerulein stimulated transcriptional activation of NF-kB or AP-1, which resulted in the upregulation of the critical proinflammatory mediators in pancreatic fibrosis.
Transient Transfection of Dominant-Negative Type II Receptor of TGF-b Abolished the TGF-b-Induced Activation of PSCs
Mouse PSCs were isolated from normal FVB/N mice and cultured. After 3 passages after isolation, cells were further activated with 5 ng/mL recombinant TGF-b1. a-SMA and fibronectin protein expression was detected by immunofluorescence staining and observed with confocal microscopy (Fig. 5A) . Expression of a-SMA and fibronectin was significantly induced by TGF-b stimulation and the proteins predominantly expressed in cytoplasm and membrane portion of PSCs. However, the cells transfected with dominant-negative TGF-b type II receptor were not activated even after TGF-b1 treatment, suggesting that the loss of TGF-b signaling abolished the activating action of TGF-b1 on PSCs. Similarly, significantly decreased expression of a-SMA was observed in PSCs transiently transfected with TGF-b dnRII compared with mock-transfected PSCs (Fig. 5B) .
DISCUSSION
Though the exact molecular mechanisms involved in development of pancreatic fibrosis are not completely understood, studies in recent years indicate that a complex interaction between various peptide growth factors are found to participate in the regulation of ECM turnover under normal conditions as well as in pathologic fibrotic reaction. 9, 10 In the current study, we showed concrete evidence that TGF-b signaling might be essential in the pathogenesis of chronic fibrosing pancreatitis, leading to either pancreatic insufficiency or carcinogenesis. Conditional loss of TGF-b signaling in the pancreas led to attenuated fibrogenic responses with repeated injections of cerulein with decreased ECM protein synthesis. All of our findings suggested the principal engagement of TGF-b signaling in the generation of chronic fibrosing pancreatitis, which served the modulation of TGF-b signaling 2/2 led to mortality due to severe infiltration of inflammatory cells in vital organs like the lung, brain, and heart, we blocked the TGF-b signaling selectively in the pancreas using the organspecific promoter of pS2/TFF1 to express dominant-negative forms of TGF-b type II receptor, enabling the blocking of TGF-b signaling only in the pancreas to avoid the mortality from the loss of TGF-b signaling.
Pancreatic regeneration from cerulein-induced pancreatitis is characterized by the proliferation of acinar and centroacinar cells, an increase in mitotic activity of fibroblasts, and increased expression and deposition of collagen, 26, 27 and the application of recombinant TGF-b promotes the development of pancreatic fibrosis after recurrent episodes of acute cerulein-induced pancreatitis in mice. 22 TGF-b has a dominant role in tissue repair after injury. That is, it promotes tissue healing by chemoattracting monocytes and leukocytes and by inducing angiogenesis, fibroblast recruitment, and ECM synthesis and controls the production of cytokines and other inflammatory mediators. 28, 29 Previous reports support that TGF-b plays a critical role in the development of pancreatitis that was detected in human specimens of acute pancreatitis and experimental pancreatitis animal model between 24 and 48 hours after induction. 20, 30 After a single induction of acute pancreatitis, TGF-b expression did not influence remodeling, regeneration, of deposition of acinar and connective tissue. But if the episodes of acute pancreatitis are repeated at weekly intervals, pancreatic fibrosis progresses to pancreatitis in humans. 7 Therefore, TGF-b1 could be a mediator involved in the possible link between acute and chronic pancreatitis, and macrophages and fibroblasts are potential sources of endogenous TGF-b in the development of chronic pancreatitis. 31 Therefore, this shows that the TGF-b is a major factor for ECM accumulation for the development of chronic pancreatitis.
The major constituents of ECM in chronic pancreatitis are fibronectin and collagen type I, III, and IV. 32 A previous study reported that TGF-b and its signaling receptors are upregulated in human acute necrotizing pancreatitis in a concomitant fashion with collagen type I mRNA, suggesting that the growth factors play a critical role either in pancreatic tissue remodeling or in the fibrotic repair of the necrotic areas. 13 Since TGF-b is a major growth factor in pancreatic ECM assembly, blocking of the TGF-b receptor could attenuate synthesis of ECM proteins in pancreatic tissue as shown in our study. In addition, TGF-b1 promotes fibrogenesis not only by the increased collagen production but also by the inhibiting matrix metalloproteinases (MMPs) in the pathways of collagen degradation. 33 In both human and experimental pancreatic fibrosis, TGF-b has been observed in the atrophic acinar cells adjacent to areas of fibrosis, suggesting a paracrine secretion of TGF-b. 34 Therefore, in pS2-dnRII transgenic mice, the autocrine and paracrine effects of TGF-b might be lost. Besides TGF-b1, several growth factors such as interleukin-6, 35 TGF-a, 36 epidermal growth factor, 37,38 and fibroblast growth factor 39 are all critical participants in the fibrotic process of chronic pancreatitis. This evidence suggests that the modulation of TGF-b1 along with other growth factors critically involved in pancreatic fibrosis could promise to prevent the fibrosis of pancreas. PSCs play a central role in the development of fibrosis in response to chronic pancreatic injuries from various causes 40 and are activated by proinflammatory cytokines. 40, 41 For that, secreted TGF-b has autocrine and paracrine effects on PSCs. 33, 42 The a-SMA in pancreatic tissue was significantly more decreased in pS2-dnRII transgenic mice than wild-type littermates, resulting in attenuated pancreatic fibrosis even after repeated challenges. Therefore, further investigation may be needed to define whether it derived from the primary effect of dnRII TGF-b on acinar cells or the results of the loss of effective TGF-b signaling of PSCs since PSCs had been known to be principally responsible for fibrosis.
In pancreatic fibrosis, activated PSCs acquire the proinflammatory phenotype, which may modulate the recruitment and activation of inflammatory cells. NF-kB, AP-1, and SP-1 are primarily responsible for transcriptional regulation in immediate early response genes in PSC activation. 43 Overall, COX-2 has been shown to have a close relationship with PSC activation, and its promoter regions contain a functional binding site for the transcriptional factors NF-kB and AP-1. 44 Our previous finding suggested that the transcriptional factors NF-kB and AP-1 played a very important role in pancreatic fibrosis, especially for PSC activation. In cell culture experiment using PSC, loss of TGF-b signaling in PSC showed to resist the development of pancreatic fibrosis.
In conclusion, TGF-b might play a major role in the development of pancreatic fibrosis, and the blocking of TGF-b signaling can provide a possible therapeutic target for chronic pancreatitis with fibrosis.
